Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Janet M.

Janet M. Brunsilius, Escondido, CA US

Patent application numberDescriptionPublished
20100001787DYNAMICALLY-DRIVEN DEEP N-WELL CIRCUIT - A circuit includes an NMOS transistor having a drain and a source, a p-well containing the drain and the source, an n-well under the p-well, and a first well switch configured to selectively connect the n-well to a predetermined voltage in response to an enable phase of a first switching signal. The first well switch can be configured to connect the n-well to the predetermined voltage during the enable phase of the first switching signal and to electrically float the n-well during a non-enable phase of the first switching signal.01-07-2010
20110025407DYNAMICALLY DRIVEN DEEP N-WELL CIRCUIT - A circuit can include an NMOS transistor having a drain and a source, a p-well containing the drain and the source, an n-well under the p-well, a circuit node, and a connection element connecting the n-well to the circuit node. The connection element can include a diode having an anode terminal connected to the circuit node and a cathode terminal connected to the n-well, a resistor having a first terminal connected to the circuit node and a second terminal connected to the n-well, a conductor directly connecting the n-well to the circuit node, or a well switch configured to connect the n-well to the circuit node during an enable phase of a switching signal and to electrically float the n-well during a non-enable phase of the switching signal. The diode can include a diode-connected transistor. The circuit node can be configured to receive a predetermined voltage having a magnitude equal to or greater than an upper supply voltage.02-03-2011

Janet M. Catov, Pittsburgh, PA US

Patent application numberDescriptionPublished
20110129551SOLUBLE CD117 (SC-KIT) FOR DIAGNOSIS OF PREECLAMPSIA AND ECLAMPSIA - This disclosure relates to methods of predicting and diagnosing preeclampsia and eclampsia in pregnant subjects. These methods include detecting a decrease of soluble c-kit in a sample obtained from the pregnant subject. A significantly reduced concentration of soluble c-kit in the sample as compared to a gestational age-adjusted control indicates that the pregnant subject will develop or has preeclampsia or eclampsia.06-02-2011

Janet M. Goslee, Columbia, SC US

Patent application numberDescriptionPublished
20100258613MEDICAL MANAGER - A system for alerting medical emergency personnel to a medical history of a patient. The system has a primary identifier suitable for attachment near an entrance to a building. The primary identifier has an indicia noting that a tri-fold portfolio is present. A secondary identifier is provided suitable for placement in the building wherein the secondary identifier has the indicia and a location of the tri-fold portfolio. The tri-fold portfolio has an outer portion with a top front cover and a bottom front cover with a back hingedly attached there between. Cascading file folders are attached to an interior of the back wherein when the top front cover and the bottom front cover are folded the cascading file folders are covered.10-14-2010

Janet M. Sofy, Troy, MI US

Patent application numberDescriptionPublished
20100308068PIVOT LID WASTE BASKET - The subject invention is a lid assembly (12-09-2010

Janet M. Srack, Bennington, KS US

Patent application numberDescriptionPublished
20090290759STEREOSCOPIC MEASUREMENT SYSTEM AND METHOD - A stereoscopic measurement system captures stereo images and determines measurement information for user-designated points within stereo images. The system comprises an image capture device for capturing stereo images of an object. A processing system communicates with the capture device to receive stereo images. The processing system displays the stereo images and allows a user to select one or more points within the stereo image. The processing system processes the designated points within the stereo images to determine measurement information for the designated points.11-26-2009
20090290786STEREOSCOPIC MEASUREMENT SYSTEM AND METHOD - A stereoscopic measurement system captures stereo images and determines measurement information for user-designated points within stereo images. The system comprises an image capture device for capturing stereo images of an object. A processing system communicates with the capture device to receive stereo images. The processing system displays the stereo images and allows a user to select one or more points within the stereo image. The processing system processes the designated points within the stereo images to determine measurement information for the designated points.11-26-2009
20090290787STEREOSCOPIC MEASUREMENT SYSTEM AND METHOD - A stereoscopic measurement system captures stereo images and determines measurement information for user-designated points within stereo images. The system comprises an image capture device for capturing stereo images of an object. A processing system communicates with the capture device to receive stereo images. The processing system displays the stereo images and allows a user to select one or more points within the stereo image. The processing system processes the designated points within the stereo images to determine measurement information for the designated points.11-26-2009

Janet M. Wenzlau, Greenwood Village, CO US

Patent application numberDescriptionPublished
20100143374DIAGNOSTIC AND THERAPEUTIC TARGET FOR AUTOIMMUNE DISEASES AND USES THEREOF - Described is the identification of ZnT8 as an autoantigen target in type I autoimmune diabetes (T1D), other autoimmune disease, and other diabetes-linked diseases and conditions. Also described are a variety of therapeutic, diagnostic, and prognostic tools and methods based on this discovery. The identification of genetic variation in ZnT8 as an important player in the initiation of the disease process and the progression of autoimmunity to clinical diabetes is disclosed.06-10-2010

Janet M. Wilson, Essex Junction, VT US

Patent application numberDescriptionPublished
20100264545Metal Fill Structures for Reducing Parasitic Capacitance - Vertically-staggered-level metal fill structures include inner contiguous metal fill structures and outer contiguous metal fill structures. A dielectric material portion is provided between each contiguous metal fill structure. Vertical extent of each contiguous metal fill structure is limited up to three vertically adjoining metal interconnect levels, thereby limiting the capacitance of each contiguous metal fill structure. Capacitive coupling between the contiguous metal fill structures and the metal interconnect structures is minimized due to the fragmented structure of contiguous metal fill structures.10-21-2010